Early postmarket results with PulseRider for treatment of wide-necked intracranial aneurysms: a multicenter experience.

CONCLUSIONS: PulseRider is being used in both on- and off-label cases following FDA approval. The clinical and radiographic outcomes are comparable in real-world experience to the outcomes observed in earlier studies. Further experience is needed with the device to determine its role in the neurointerventionalist's armamentarium, especially with regard to its off-label use.
PMID: 31703202 [PubMed - as supplied by publisher]

Source: Journal of Neurosurgery - November 7, 2019 Category: Neurosurgery Authors: Srinivasan VM, Srivatsan A, Spiotta AM, Hendricks BK, Ducruet AF, Albuquerque FC, Puri A, Amans MR, Hetts SW, Cooke DL, Ogilvy CS, Thomas AJ, Enriquez-Marulanda A, Rai A, Boo S, Carlson AP, Crowley RW, Rangel-Castilla L, Lanzino G, Chen PR, Diaz O, Bohnst Tags: J Neurosurg Source Type: research